These final results, together with a earlier report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 aid the idea of targeting ACKR3 as a novel method to modulate the opioid process, which could open up new therapeutic avenues for opioid-connected disorders. At that point, Microsoft https://bernardg925idy3.wikisona.com/user